A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1177

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: BI 1015550
DRUG: Placebo

Sponsor

Boehringer Ingelheim